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Abstract-The accumulation of selected CNS drugs by rat leukocytes was previously 
reported. This paper presents evidence for the transport into leukocytes of additional drugs. 
Also studied was the inhibition of the latter processes by various structurally related com- 
pounds. The markedly rapid and sodium-independent uptakes into rat leukocytes of 
amphetamine, codeine, methadone and naloxone fulfilled the basic criteria for active trans- 
port, The uptake of morphine was apparently accomplished by more than one process. The 
affinities of the high capacity transport systems (approximate V,,.,: 100 nmoles/g cells/5 set) 
varied considerably as reflected by the two extreme K, values obtained for methadone (20 
PM) and morphine (1.8 mM). A variety of amines inhibited the cellular transport of the 
drugs, Most potent inhibitors were quinacrine (K,: 0.5 to 3 PM). desipramine (Ki: 6-20 PM) 
and methadone (Ki: 18-25 pM). Morphine and tryptamine exhibited inhibition constants 
higher than 1 mM. The cellular transport processes newly described in rat leukocytes appar- 
ently represent a novel addition to the heterogenous biological transport of basic amines. 
The structural specificity of amine transport in various tissues is discussed. 
WITHIN the growing mterest in the biological effects of drugs, numerous studies have 
been made on drug distribution and the interaction of drugs with cellular com- 
ponents. The biological transport of drugs received relatively little attention. Most 
of the available information referring to the latter processes focuses on the physiolo- 
gical transport of drugs, emphasizing the uptake of these compounds into various 
organs.’ A recent review of drug transport’ disclosed the lack of systematic investiga- 
tions of the mechanisms by which drugs enter cells. 
Within our study of cellular drug transport, we have previously described the 
active transport of benzomorphans in leukocytes, which were used as model mam- 
malian cells.3%4 The presented data suggested that the transport process in leukocytes 
is different from the uptake system for various amines, described in the blood plate- 
let.5P9 Recently we reported that, in addition to benzomorphans, leukocytes also 
accumulated methadone and morphine.” 
The present paper provides evidence for the active transport in leukocytes of 
further CNS drugs. In addition to the characterization of the transport processes, 
the effects of various compounds on the cellular uptakes were investigated. The cellu- 
lar transport of drugs in leukocytes is discussed in light of the hitherto described 
uptake processes for amines in various tissue. 
* Send requests for reprints to: Dr. Fedor Medzihradsky, Department of Biological Chemistry, The 
University of Michigan Medical School, Ann Arbor, Mich. 48104, U.S.A. 
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EXPERIMENTAL PROCEDURES 
Mutrrials. The drugs used in this study were kindly provided by Drs. H. H. Swain 
and J. H. Woods, Department of Pharmacology, University of Michigan. The radio- 
labeled compounds were purchased from Mallinckrodt Chemical Works, St. Louis, 
MO., except 3H-pentazocine, which was a gift from the Winthrop Research Institute, 
Rensselaer, N.Y. Plasmagel, a modified gelatin solution used for the separation of 
leukocytes, was obtained from HTI Corp., Buffalo, N.Y. The biochemicals used in 
this study, e.g. ouabain, were purchased from Sigma Chemical Co., St. Louis, MO. 
All other chemicals were of reagent grade. 
Separatiorz qf‘lrukocyte,~. Blood was obtained from the vena cavae of lightly anes- 
thetized (diethylether), male, SpragueeDawley rats. weighing 300 g. Leukocytes were 
separated by a previously developed procedure yielding blood cells with ascertained 
viability and morphological integrity.’ 1 The separated leukocytes were obtained 
within 2 hr after the collection of blood with an average yield of 59 per cent. This 
yield corresponded to 8.5 x 10” cells/ml of blood. 
Corditiors of’ irzcuhatior~ a/~cl yumtitution qf’ druy uptakr. Throughout this study, 
an incubation medium was used containing the following final concentrations (mM): 
NaCl, 133; KCl, 5.3; MgSO,; 1.3; Na,HPO,, 13.3; and glucose. 10. The pH of the 
medium was adjusted to 7.4 with HCl. After the isolation, the leukocytes were sus- 
pended with the above medium to yield a concentration of approximately 10’ cells/ 
ml. Prior to the addition of drugs, this cellular suspension was routinely incubated 
for 1 hr at 37”. To 1 ml of the preincubated leukocite suspension was rapidly added 
1 ml of incubation medium containing either the drug, the cellular uptake of which 
was investigated, or both the transported drug and the compound used as potential 
inhibitor. The amount of the drugs in the added aliquot corresponded to twice the 
desired final concentration during the incubation. The added solution also contained 
0.1 PCi of the transported radiolabeled drug. The incubation was carried out at 37. 
for the times indicated. Due to the rapid cellular uptakes, the linear ranges of drug 
transport necessitated the termination of the incubation between 5 and 60 set after 
the addition of the particular drug. 
The incubated cell suspension was quickly filtered through glass-fiber filters sup- 
ported on a Millipore assembly. The filters were previously thoroughly washed with 
0.90/, NaCl by repeated suspension and decantation. In order to reduce the extent 
of nonspecific binding of radioactive compounds, the pretreated filters were finally 
washed in 0.9% NaCl saturated with N-amyl alcohol. The cells on the filter were 
rapidly washed three times with 6 ml each of ice-cold 0.9:/, NaCI. The filters were 
then placed in standard glass scintillation vials and covered with 0.3 ml of Protosol. 
The vials were capped and incubated at 55’- for 2 hr in order to complete digestion 
of the biological material. After the vials were cooled to room temperature, 10 ml 
of a scintillation medium (5 PPO and 0.3 g dimethyl-POPOP/l. of toluene”) was 
added. The radioactivity was measured in a scintillation spectrometer, Packard, 
model 3320. The average counting efficiencies for “H- and 14C-labeled compounds 
were 45 and 80 per cent, respectively. as determined by the method of internal stan- 
dardization. Appropriate blanks were run through the whole procedure. Even in ex- 
periments in which low uptakes were observed, the blanks did not exceed 50 per cent 
of the measured net counts. 
* PPO = 2,5-diphenyloxwole: POPOP = 1.4.his-2-(5-phenylox~zolyl)-benzene. 
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In control experiments, carried out to establish binding of drug to cellular mater- 
ial, the above described incubations were performed using leukocytes previously 
freeze-thawed or heated. Suspensions of leukocytes in the standard incubation 
medium were frozen by immersion in a mixture of dry ice and acetone at - 70” and 
then thawed at room temperature. After repeating the freeze-thaw step, the cells were 
kept at 37”. In other experiments, suspensions of cells were heated at 80” for 7 min 
and subsequently kept at 37”. After the above described treatments, the uptake of 
radiolabeled pentazocine was determined. 
In experiments carried out to investigate the effect of temperature on the transport 
process, the cellular uptake of drug was determined at O”, 18” and 36”. Leukocytes, 
suspended in the standard incubation medium, were incubated for 60 min at the indi- 
cated temperatures. Subsequently, radiolabeled drug was added and the cellular 
uptake determined. 
Expression ofresults. The rate of cellular uptake was expressed as moles of drug 
accumulated/g of leukocytes and time. One g leukocytes, packed by centrifugation, 
corresponded to an average cell count of lo9 and to 67 mg protein respectively. l1 
The results are presented as mean values ? the standard deviation. The inhibition 
constants (Ki) were calculated from the appropriate intercepts in the Lineweaver- 
Burk plots of the uptake in the presence and absence of inhibitor. In addition, Ki 
values were estimated graphically according to the method of Dixon.12 
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FIG. 1. Time course of the uptakes of codeine and methadone by rat leukocytes. Suspensions of cells were 
incubated at 37” for the various times indicated, using the medium (pH 7.4) described in the text. The 
initial concentration of the drug in the incubation medium is shown in the figure by the dotted lines. The 
conditions for the determination of cellular uptake, by quantitating the radiolabeled drug, were as de- 
scribed in Methods. One g leukocytes corresponded to approximately lo9 cells. Plotted are mean values 
_t SD. of at least four separate experiments in which different preparations of leukocytes were used. 
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RESULTS 
Characterization of leukocytes. Yield and purity of the cells as well as their mor- 
phological integrity and viability were ascertained in an earlier study.” Cross- 
contamination by other blood cells of the leukocyte preparation was less than 3 per 
cent. In addition to thorough microscopic examination of the stained cellular prep- 
arations, the investigated parameters of viability were: trypan blue exclusion. deter- 
mination of the cellular contents of K+, Naf and adenosine triphosphate. and 
measurements of oxygen consumption. These criteria of cellular viability were ful- 
filled over an incubation period at 37’ of 334 hr after the isolation.’ ’ 
Time-depedent uptake ofdrugs. The transport of drugs into leukocytes was char- 
acterized by a markedly rapid rate of uptake (Figs. l- 3). Due to the fast transport. 
the linear ranges of drug uptake were limited to a narrow time interval. All the inves- 
tigated drugs, when present at a concentration below their corresponding K,,, value 
(Table I), were accumulated in leukocytes. The extent of cellular accumulation at 
saturation depended on the external concentration and was 4-fold at low contents 
of the particular drug in the medium. Accumulation of morphine, however, was 
obtained only at a concentration in the medium of less than one-third of its K,,, value 
(Fig. 3). 
Uptuke by disrupted cells. Both heat treatment and freezing of leukocytes strongly 
reduced the cellular uptake of drugs. The data in Table 2 show a decrease of 85 per 
cent in the accumulation of pentazocine in previously treated leukocytes as com- 
pared to control cells. An exception in this relation was observed with morphine, the 
incubation of which with heat-treated leukocytes resulted in increased radioactivity 
AMPHETAMINE 




FIG. 2. Time course of the uptakes of amphetamine and naloxone by rat leukocytes. (SW alao legend to 
Fig. 1.) 




FIG. 3. Time course of the uptake of morphine by rat leukocytes. Suspensions of cells were incubated 
at 37’ for the various times indicated. using the medium (pH 7.4) described in the text. The cellular uptake 
of morphine was investigated at three different external concentrations of the drug. The initial con- 
centration of morphine in the incubation medium is shown in the figure by the dotted lines. (See also 
legend to Fig. 1.) 
'TAISL~ 1. CIIARA~TEKIU~K)~~ ok IIKC~~TRAN~P~RT th' LEUKOCYTES* 
Transported drug 
Inhibition of transport (“J 
Apparent K,, Apparent V,,,,, NaF Ouabain 







90 lOO(5 set) 59 0 93 
200 140(5 set) 59 9 88 
20 115(5sec) 50 10 80 
1800 I 200 (60 set) 19 4 89 
180 210(30sec) 55 0 80 
40 lOO(5 set) 57 3 85 
* The listed kmctic constants of drug uptake were obtained in the experiments shown in Figs. 46. In 
investigating the inhibition of drug transport. rat leukocytes were preincubated with the inhibitors at 37” 
for 60 min in the medium described in the text. In other experiments, suspensions of cells were kept for 
60 min at 0 After these treatments. a solution of the investigated drug in the incubation medium was 
added. The final concentrations of the drugs were lower than their respective K, values. The conditions 
for the determination of cellular drug uptake were as described in Methods. The numbers listed represent 
mean values ofat least four separate experiments in which different preparations of leukocytes were used. 
of the cellular material. however, the latter effect was not observed when frozen- 
thawed leukocytes were used. 
Kirwtic parameters ofdruy trunsport. The Lineweaver-Burk plots of the uptakes 
are shown in Figs. 4-6. The numerical values for the apparent K, and V,,, are sum- 
marized in Table 1. In these experiments drug uptake had to be determined at 
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TABLE 2. UPTAKE OF PEPXAZOCINE BY LEUKOCYTES PREVIOUSLY FREEZE- 






Rate of pentazocine 
uptake 
(nmoles/g cells x 5 set) 
12.7 i 2.9 
1.8 f I.0 
1.9 + I.0 
* Control cells were maintained at 37” at all times. The treatment 
of other leukocytes and the determination of the uptake of radiola- 
beled pentazocine were as described in Methods. The concentration of 
pentazocine in the incubation medium was in all cases 10 PM. Pre- 
sented are mean values + SD. of four separate experiments in which 
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FIG. 4. Lineweaver-Burk plots of the uptake of codeine and methadone by rat leukocytes. Plotted are 
the reciprocal initial concentrations of the drugs in the medium against the corresponding reciprocal cell 
contents at the times indicated. The obtained values for K, and V,,,,, are listed in Table 1. The conditions 
of drug quantitation were as described in Methods. Presented are mean values of at least four separate 
experiments in which different preparations of leukocytes were used. 
various times in order to investigate the linear range of the transport process. On 
the basis of their apparent K, values, the transported drugs can be divided into three 
groups. In order of decreasing affinity these groups are: methadone and pentazocine; 
amphetamine; naloxone and codeine; morphine. A less pronounced differentiation 
among the drugs was obtained by comparing their rates of transport. Except for 
naloxone, the apparent V,,,,, values of the other drugs were similar, ranging from 100 










I/DRUG CONCENTRATION (I/&M) 
FE. S. Lineweaver-Burk plots of Ihe uptake of amphetamine and naloxone 
Icgend to Fig. 4.) 
by rat leukocytes. (See dS0 
l/DRUG CONCENTRATION (I/mM) 
FIG. 6. Lineweaver-Burk plot of the uptake of morphine by rat leukoqtes. Plotted arc the reciprocal in- 
itial concentrations of the drug in the medium against the reciprocal cell content at the times indicated. 
(See also &end to Fig. 3.) 
to 140 nmoles/g cells/5 sec. Naloxone was transported into leukocytes with a V,,, 
of 35 nmoles/g/5 sec. 
Charactrrizatior~ qf’ the uptuke process. In the presence of sodium fluoride, the 
uptake of most drugs decreased by 50-60 per cent as compared to the controls (Table 
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1). Again, the exception was morphine, the transport of which was affected only 19 
per cent. Ouabain had little or no effect on the transport of the investigated drugs 
and the uptake of all the drugs was strongly reduced at 0”. The Arrhenius plot, i.e. 
log V,,, plotted against l/T (OK), generated for the temperature dependence of the 
uptake of pentazocine, was linear with temperature in the range from 0” to 36” (Fig. 
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FIG. 7. Arrhenius plot of V,,, values for the uptake of pentazocine. The slope of the line corresponds to 
a Q,,, of 2.05. The experimental conditions were as described in Methods. Presented are mean values 
obtained from three separate experiments. 
The effects of temperature and of metabolic inhibitors on the cell count and on 
the viability of leukocytes were determined (Table 3). Relative to the controls, none 
of the investigated conditions caused changes in either the total cell count or the per 
cent of leukocytes stained by trypan blue. 
TABLE 3. EFFECTOFTEMPEKATUREANDOFMETAROLICINHIBITORSONCELL COUNT AND 





Uptake of trypan 
blue 





3 mM Iodoacetamide 
I.08 x IO’ 
1.07 X 10’ 
I.06 x IO’ 
8.6 X IO” 
9.0 x IO” 
Control 9.6 x IO 
3 mM NaF 9.2 X lo6 









* Suspensions of leukocytes were exposed to the indicated conditions for 60 min. 
Control cells were suspended in the standard incubation medium and kept at 37”. 
Incubations with inhibitors were carried out at 37’. Aliquots of the control and of 
treated cellular suspensions were incubated with O.lSYO trypan blue for 15 min at 37”. 
Presented are the results of a typical experiment. 


















Transported drugs and their initial external concentration (PM) 
Amphetamine Codeine Methadone Morphine Naloxone Pentazocine 
(10) (50) (10) (200) (50) (10) 
X5 1 IO > 1000 75 I 00 
160 I50 120 > 1000 I25 100 
200 200 > 1000 I60 220 
6 20 8 > 1000 I5 8 
45 65 60 > 1000 45 40 
130 170 I 30 60 140 
IX 25 400 25 22 
> IO00 > 1000 > 1000 > IO00 > IO00 
230 350 ‘00 90 355 
I50 250 250 > 1000 200 
30 100 40 > 1000 40 
, 3; 65 2 40 2.5 200 IO ‘5 0.5 45 3 
> 1000 > I 000 > 1000 > 1000 > 1000 
* In addition to the data on the inhibition. the initial concentrations of the transported drugs in the 
incubation medium are listed. The inhibitor was added to suspensions of leukocytes simultaneously with 
the transported drug. Further conditions of the experiments were as described in Methods. The K, values 
were calculated from the corresponding intercepts in Linewaker Burk plots of the uptake in the presence 
and absence of inhibitor. The inhibition constants were also estimated graphically from corresponding 
Dixon plots of the data. Presented are mean values of at least four separate experiments in which difierent 
preparations oflcukoqtes wcrc used. 
Irlhihition of‘cellular rlwy tmnsport. The described transport processes were com- 
petitively inhibited by a variety of compounds. According to their decreasing poten- 
cies as inhibitors, the compounds in Table 4 can be divided into the following 
groups: quinacrine. desipramine and methadone; thebaine, pentazocine and levallor- 
phan: amphetamine and cocaine; codeine. naloxone and nalorphine; morphine and 
tryptamine. Quinacrine proved to be a markedly potent inhibitor of all the investi- 
gated processes including the uptake of morphine. The latter process, however, was 
not particularly affected by desipramine, an otherwise strong inhibitor of cellular 
drug transport in leukocytes. Whereas the inhibition constants for the various com- 
pounds ranged from 05 to 350 /tM, in inhibiting the uptake of morphine only 
quinacrine. desipramine and thebaine exhibited Kj values in the submillimolar range. 
DISCUSSION 
There is a lack of information concerning processes by which drugs enter cells. In 
view of the possible role of cellular transport in the overall biologic action of drugs, 
the investigation of the latter processes in human cellular preparations becomes of 
great interest. The convenient availability of blood cells in general and the morpho- 
logical characteristics of leukocytes in particular led us to investigate the processes 
by which drugs cross the plasma membrane of these model mammalian cells. 
Our first results indicated that pentazocine. a potent analgesic widely used clini- 
cally, is transported into leukocytes by a process that fulfilled all the basic criteria 
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for active transport.3 Furthermore, the markedly rapid cellular uptake of pentazo- 
tine correlated well with the fast onset of analgetic action of this drug and its rapid 
entry into the brain after intraperitoneal administration to ratsi In addition to pen- 
tazocine, other CNS drugs were also found to be actively transported into leuko- 
cytes. lo 
A comparison of the characteristics of the transport processes in leukocytes with 
those described for the accumulation of various organic bases in plateletssP9 suggests 
a different mechanism for the phenomena observed in leukocytes. Whereas the 
uptakes by platelets were strongly inhibited by ouabain, suggesting a role of mono- 
valent cations, this cardiac glycoside had little or no effect on the drug transport in 
leukocytes (Table 1). Additional characterization of the described uptakes of CNS 
drugs showed that these compounds were accumulated in leukocytes against their 
concentration gradient by a saturable process which was strongly affected by tem- 
perature and sodium fluoride. The latter finding is in agreement with the results of 
previous work in which the effects of additional metabolic inhibitors were investi- 
gated. 3~10 The marked effects of temperature and metabolic inhibitors were further 
substantiated by the proven viability of the cells exposed to these conditions (Table 
3). The expression of cellular drug concentration on the basis of cell water, amount- 
ing in leukocytes to 79 per cent,i4”’ would increase the apparent accumulation ratio 
of the drugs in these cells. Evidence for the presence intracellularly of the transported 
drug in its unaltered form was obtained by the similarity of results of experiments 
in which the cellular drug content was determined by both gas-liquid chromat- 
ography and radioactive measurements.3.10 
The described uptakes apparently required an intact plasma membrane: transport 
into leukocytes was strongly reduced after repeated freezing and thawing and after 
previous heating of the cells (Table 2). Additional evidence against protein binding 
as the underlying mechanism of drug accumulation was provided by the following 
data: inhibition of the uptake by metabolic inhibitors (Table l), effect of temperature 
resulting in a Q , o of 2 (Fig. 7) and dependence of the uptake on the presence of glu- 
cose in the incubation medium.3 These results, together with the saturability of the 
cellular accumulation and the competitive inhibition by chemical analogs, strongly 
suggest the presence in the leukocyte membrane of an active transport process for 
the investigated compounds. A direct relationship between the uptake of drugs into 
leukocytes and the cellular concentration of adenosine triphosphate was recently 
established.16 Whether the transported unaltered drug is bound intracellularly can 
not be directly resolved at this time. However, the markedly rapid efflux observed 
for pentazocine provides evidence against a tight intracellular binding of the drug. lh 
The uptake of morphine was characterized by exceptions. In addition to its dis- 
tinctly low affinity for morphine (Table l), the transport process was only weakly 
affected by sodium fluoride. The latter finding suggests that the uptake of morphine, 
as opposed to that of the other investigated drugs, is only partly based on active 
transport requiring metabolic energy. After carotid injection of the drugs. markedly 
higher uptake into brain of codeine and methadone relative to morphine was 
recently reported. ’ ’ 
The variety of compounds exhibiting competitive inhibition of the uptake into 
leukocytes of CNS drugs (Table 4) raises the question about the structural require- 
ment of the transport process. The common structural property of all the compounds 
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investigated in this study was their amine character. All but one of them represented 
substituted basic amines with the latter group removed from an aromatic residue by 
3-4 carbon atoms. An exception was amphetamine. which as a primary amine com- 
petitively inhibited the cellular drug transport. On the other hand, tryptamine had 
little effect on the investigated uptake processes. Substitution in the aromatic ring 
showed no definite correlation with the affinity of the particular compound in the 
transport and/or with its potency as inhibitor. However, methylation of the phenolic 
hydroxyl group considerably decreased the respective Ki value, as was seen in the 
series, morphine, codeine and thebaine. 
There is considerable evidence for the accumulation of various amines in different 
tissues. Particularly well investigated is the uptake of these compounds by various 
preparations from brain l8 and by blood platelets-” The uptake of biogenic amines 
in preparations from brain was apparently highly sodium dependent and selectively 
affected by specific drugs; e.g., in brain slices and synaptosomes, desipramine 
strongly inhibited norepinephrine uptake, affected to a lesser degree the transport 
of serotonin, and had no effect on dopamine uptake.’ *x1 9 The heterogeneity of amine 
transport was underlined by a detailed study on the structural specificity of norad- 
renaline uptake by cardiac tissue, in which the inhibitory potencies of 43 drugs were 
investigated.*’ The results of that study are in considerable contrast to our findings 
in leukocytes: the optimal chemical structure for an inhibitor seemed to be a primary 
amine and the aromatic ring was not an essential structural feature. Phenolic hy- 
droxyl groups increased the effect, whereas 0-methylation led to a striking decrease 
in inhibitory potency of a compound. 
A common characteristic of the processes by which various organic bases were 
accumulated by blood platelets was their dependency on sodium. Ouabain, in addi- 
tion to metabolic inhibitors, strongly inhibited the uptake of these compounds.5m9 
The 2- to 3-fold accumulation of methyl-glyoxal-his-guanylhydrazone in normal 
and leukemic leukocytes was reported earlier.’ ‘J’ The uptake derived its energy re- 
quirement from glycolysis and was inhibited 20 per cent by ouabain. The reported 
K,, values ranged from 50 to 200 PM. The V,,, of about 12 nmoles/min/2 x lo8 cells 
was approximately 100 times slower than the rates observed in the present study. 
In addition, the structural requirements of the transport process were quite different: 
the presence in the transported molecule of at least two amine groups separated by 
four or more intervening atoms was required. Monoamines were ineffective. 
The 3- to 4-fold accumulation of “C-benzylamine in Ehrlich cells was reported 
to be the result of a rapid saturable as well as nonsaturable uptake process.23 The 
saturable process showed characteristics different from those of the amino acid trans- 
port system in these cells and was sodium independent. The affinity of the system 
for benzylamine was moderate, exhibiting a K, of 0.3 mM. 
On the basis of their characteristics, the uptake processes described in this paper 
for the transport into leukocytes of various pharmacologically active amines are 
apparently different from most of the hitherto described transport systems for these 
compounds. Although the overall characteristics of the process, described in Ehrlich 
cells. for the uptake of benzylamine are quite similar to those describing the drug 
transport in leukocytes, further work is needed to establish the relationship of these 
processes. Results of on-going studies in this laboratory on drug transport in cellular 
preparations from nervous tissues should also aid in evaluating the biologic role of 
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the processes existing in leukocytes. In connection with the latter aspect. the con- 
siderable capacity of the transport systems in leukocytes is of interest. In rat leuko- 
cytes this capacity calculates to approximately 1.2 m-moles/min/kg of cells. On the 
basis of this figure, it can be calculated that about 20 mg of one of these drugs, assum- 
ing a molecular weight of 300, can be transported per min into the leukocytes of a 
person with an average weight. The existence of the described transport processes 
in human leukocytes was established.* 
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